Publicacións en colaboración con investigadores/as de University of Hasselt (18)

2024

  1. Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial

    European Journal of Internal Medicine

2023

  1. Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 25, Núm. 9, pp. 1571-1583

  2. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension

    European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 936-955

2022

  1. Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk

    Journal of the American College of Cardiology, Vol. 80, Núm. 13, pp. 1220-1237

2021

  1. Dual antiplatelet therapy after PCI in patients at high bleeding risk

    New England Journal of Medicine, Vol. 385, Núm. 18, pp. 1643-1655

  2. Guidance on the management of left ventricular assist device (LVAD) supported patients for the non-LVAD specialist healthcare provider: executive summary

    European Journal of Heart Failure, Vol. 23, Núm. 10, pp. 1597-1609

  3. HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the community

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4394-4408

  4. HFA of the ESC position paper on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider Part 3: at the hospital and discharge

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4425-4443

  5. Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4409-4424

  6. Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study

    ESC Heart Failure, Vol. 8, Núm. 6, pp. 4685-4692

2020

  1. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1424-1437

  2. Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study

    Atherosclerosis, Vol. 295, pp. 45-53

  3. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial

    Circulation, Vol. 142, Núm. 25, pp. 2431-2442

2019

  1. Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study

    American Heart Journal, Vol. 209, pp. 97-105

  2. Effects of serelaxin in patients with acute heart failure

    New England Journal of Medicine, Vol. 381, Núm. 8, pp. 716-726

2018

  1. Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

    European Journal of Heart Failure, Vol. 20, Núm. 7, pp. 1081-1099

  2. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    The Lancet, Vol. 392, Núm. 10151, pp. 940-949

2016

  1. Contemporary management of acute right ventricular failure: A statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 18, Núm. 3, pp. 226-241